ResearchPoint Global Report issue

For profit Phase 2 Phase 3
Founded: Austin TX United States (1999)
Status: Acquired by WuXi (2017)

Organization Overview

First Clinical Trial
2008
NCT00794976
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

ResearchPoint | ResearchPoint Global

Active Ingredients

Drugs in Phase 3 Trials (1)

hydroxyprogesterone (Delalutin) (1 trial)

Drugs in Phase 2 Trials (3)

anx005 (1 trial)

immune globulin (human) (Gamastan) (1 trial)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Guillain-Barre Syndrome (Phase 2)

Premature Birth (Phase 3)

Syndrome (Phase 2)

Tennis Elbow (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 4